Genzyme Corporation (GENZ) 57.19 -0.03

Trade GENZ
NOW!
Last Trade:57.19Short Ratio:2.70
Last Trade Time:12:12pmDay Range:56.85 - 57.48
Ask:57.19Year Range:47.09 - 63.47
Bid:57.18One Year Target:58.84
Open:57.07Exchange:NasdaqNM
Volume:541363EBITDA:1.083B
Prev. Close:57.22Market Cap:15.218B
50 Day Moving:55.8823Div Yield:
200 day moving:53.6735PE:37.13

Related RealMoney articles from TheStreet.com

Icahn Scolds Genzyme: BioBuzz
Exclusive: Genzyme In Icahn's Sights

Genzyme Upward Momentum Looks to Continue (GENZ)

Posted on 03/15/10 at 12:51pm
SmarTrend identified an Uptrend for Genzyme (NASDAQ: GENZ) on January 08, 2010 at $52.60. In approximately 2 months, Genzyme has returned 8.7% as of today's recent price of $57.17.
Click here to read the rest of the article

EHSI Signs Option with Biotech Firm Celulas Genetica

Posted on 03/15/10 at 9:12am
HOUSTON--(BUSINESS WIRE)-- Emerging Healthcare Solutions, Inc.
Click here to read the rest of the article

Stock Market Movers On FDA's Decision (BSX, MNKD, IPXL, GENZ, MRK, ISIS)

Posted on 03/15/10 at 3:00am
(EMAILWIRE.COM, March 15, 2010 ) Dallas, Tx - Boston Scientific Corporation (NYSE:BSX) plunged 19% to $6.33 after making a fresh 52-week low of $6.31 earlier in the session.
Click here to read the rest of the article

Top Takeover Targets In The Biotechnology Sector This Year (VRTX, AUXL, CELG, ITMN, GENZ)

Posted on 03/09/10 at 9:09pm
Analysts at Morningstar have compiled a list of top takeover targets in the biotechnology sector this year. Morningstar said that it weighed drug portfolio strength, fit with potential partners, profit-boosting power, and financial health in assessing the chances of a takeover.
Click here to read the rest of the article
Posted in

Uptrend Spotted in Shares of Genzyme (GENZ)

Posted on 03/05/10 at 12:27pm
SmarTrend identified an Uptrend for Genzyme (NASDAQ: GENZ) on January 08, 2010 at $52.60. In approximately 2 months, Genzyme has returned 8.8% as of today's recent price of $57.25.
Click here to read the rest of the article

Investors Bid Up Shares of Genzyme, Up 0.7% (GENZ)

Posted on 03/03/10 at 1:09pm
Genzyme (NASDAQ: GENZ) is one of today's best performing stocks, up 0.7% to $57.23. The S&P is currently trading 0.6% higher to 1,125 and the Dow Jones Industrial Average is trading 0.5% higher to 10,459.
Click here to read the rest of the article

Make 50% By Copying Carl Icahn

Posted on 03/02/10 at 2:55pm
Carl Icahn is ready for a brawl... Back in October, we told you how a rogue virus had infected the manufacturing facilities of Genzyme, the biotech bellwether. The FDA ordered Genzyme to shut down its plant and cease producing Cerezyme and Fabrazyme, two of the company's most lucrative drugs. Revenue and earnings plunged.
Click here to read the rest of the article
Posted in

SmarTrend research report available on Genzyme (NASDAQ:GENZ)

Posted on 03/01/10 at 3:06pm
SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ: GENZ) at http://www.mysmartrend.com/research/
Click here to read the rest of the article